Pfizer Switzerland

Pfizer Switzerland is owned by Pfizer.

Pfizer is one of the...

Pfizer is a company listed under the stock ticker PFE (US).

Pfizer has a direct presence in 39 countries.

They are in:

Acquisition, funding and merger involving Pfizer.

Pfizer has announced the acquisition of Seagen (posted on March 13 2023).
Pfizer has announced the acquisition of Seagen (posted on February 27 2023).
Pfizer has acquired Global Blood Therapeutics (posted on October 6 2022).
Pfizer has announced the acquisition of Global Blood Therapeutics (posted on August 9 2022).
Pfizer has acquired ReViral (posted on July 20 2022).
Pfizer has announced the acquisition of Biohaven Pharmaceutical (posted on May 12 2022).
Pfizer has announced the acquisition of ReViral (posted on April 8 2022).
Pfizer has announced the acquisition of Arena Pharmaceuticals (posted on December 13 2021).
Pfizer has acquired Trillium Therapeutics (posted on November 17 2021).
Pfizer has acquired Trillium Therapeutics (posted on October 27 2021).

View the org chart displaying its 15 main executives

William Pao, Executive Vice President and Chief Development Officer, will leave the company in Aug. 2023 (posted on July 27 2023).
Chris Boshoff, who was Chief Development Officer, Oncology and Rare Disease, is promoted to Chief Oncology Research and Development Officer and Executive Vice President (posted on July 27 2023).

Create your alert
to follow the executive moves at Pfizer Switzerland.